Separate terms with OR to return results that match either term.
 
Clear All
10,000 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength (Ascending) SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
68071-5242-06 68071-5242 Prednisone Prednisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral April 24, 2020 In Use
68071-5242-07 68071-5242 Prednisone Prednisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral April 24, 2020 In Use
68071-5242-08 68071-5242 Prednisone Prednisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral April 24, 2020 In Use
53150-0314-01 53150-0314 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 20.0 mg/10mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous April 30, 2013 Dec. 31, 2017 No Longer Used
53150-0314-10 53150-0314 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 20.0 mg/10mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous April 30, 2013 Dec. 31, 2017 No Longer Used
51862-0682-00 51862-0682 TAMOXIFEN CITRATE SOLTAMOX 20.0 mg/10mL Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Dec. 6, 2021 In Use
51862-0682-01 51862-0682 TAMOXIFEN CITRATE SOLTAMOX 20.0 mg/10mL Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral June 18, 2021 In Use
67457-0394-00 67457-0394 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 20.0 mg/10mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Feb. 14, 2012 April 30, 2016 No Longer Used
67457-0394-10 67457-0394 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 20.0 mg/10mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Feb. 14, 2012 April 30, 2013 No Longer Used
16729-0247-11 16729-0247 Mitomycin Mitomycin 20.0 mg/10mL Chemotherapy Antitumor Antibiotic Alkylating Agent/ Mitomycin Intravenous May 3, 2013 Feb. 28, 2023 No Longer Used
51655-0320-18 51655-0320 Prednisone Prednisone 20.0 mg/201 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral April 29, 2014 In Use
51655-0320-20 51655-0320 Prednisone Prednisone 20.0 mg/201 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral May 1, 2014 In Use
51655-0320-21 51655-0320 Prednisone Prednisone 20.0 mg/201 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral April 29, 2014 In Use
51655-0320-30 51655-0320 Prednisone Prednisone 20.0 mg/201 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral April 29, 2014 In Use
51655-0320-53 51655-0320 Prednisone Prednisone 20.0 mg/201 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral April 29, 2014 In Use
51655-0320-54 51655-0320 Prednisone Prednisone 20.0 mg/201 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral April 29, 2014 In Use
53150-0411-01 53150-0411 Idarubicin Hydrochloride Idarubicin Hydrochloride 20.0 mg/20mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous April 30, 2013 Dec. 31, 2016 No Longer Used
69668-0120-20 69668-0120 Prednisone Deltasone 20.0 mg/20mg Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Aug. 31, 2015 In Use
69097-0369-32 69097-0369 Docetaxel Anhydrous Docetaxel Anhydrous 20.0 mg/2mL Chemotherapy Antimitotic Agent Taxane Intravenous Aug. 24, 2018 Aug. 26, 2020 No Longer Used
51144-0020-01 51144-0020 ENFORTUMAB VEDOTIN PADCEV 20.0 mg/2mL Immunotherapy Drug Antibody Conjugate Nectin-4 Intravenous Dec. 18, 2019 In Use
00069-9141-11 00069-9141 Docetaxel Docetaxel 20.0 mg/2mL Chemotherapy Antimitotic Agent Taxane Intravenous June 23, 2014 Aug. 31, 2017 No Longer Used
00069-9141-22 00069-9141 Docetaxel Docetaxel 20.0 mg/2mL Chemotherapy Antimitotic Agent Taxane Intravenous June 23, 2014 April 30, 2016 No Longer Used
71288-0143-02 71288-0143 Docetaxel anhydrous Docetaxel anhydrous 20.0 mg/2mL Chemotherapy Antimitotic Agent Taxane Intravenous Aug. 24, 2018 In Use
71288-0150-95 71288-0150 Docetaxel anhydrous Docetaxel anhydrous 20.0 mg/2mL Chemotherapy Antimitotic Agent Taxane Intravenous Aug. 24, 2018 In Use
83831-0101-02 83831-0101 Docetaxel DOCIVYX 20.0 mg/2mL Chemotherapy Antimitotic Agent Taxane Intravenous May 9, 2024 In Use

Found 10,000 results in 9 milliseconds — Export these results